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Aims Plasma B-type natriuretic peptide (BNP) is an emerging biomarker in heart failure. In this setting,
the extent of left ventricular (LV) dyssynchrony contributes to exercise symptoms. Whether exercise-
induced changes in LV dyssynchrony might be a trigger of BNP release has never been investigated.
Methods and results Fifty-seven patients with systolic LV dysfunction underwent quantitative analysis
of BNP, mitral regurgitation (MR), and dyssynchrony at rest and during exercise. None had inducible
ischaemia on perfusion imaging. By multiple regression analysis, end-systolic volume index (P, 0.0001),
effective regurgitant oriﬁce (ERO) (P , 0.001), and E/Ea (P ¼ 0.002) emerged as independent determi-
nants of BNP at baseline (R2 ¼ 0.67). Exercise induced a signiﬁcant rise in BNP levels (P, 0.0001).
In multivariate analysis, a smaller change in systolic blood pressure (P ¼ 0.04), a larger increase in
ERO (P ¼ 0.017), and in systolic dyssynchrony index (P ¼ 0.006) during exercise emerged as independent
determinants of exercise-induced increases in BNP (R2 ¼ 0.45).
Conclusion MR severity, volume overload, and LV ﬁlling pressure are surrogates of BNP at rest. During
exercise, changes in BNP reﬂect the presence of dynamic changes in both LV dyssynchrony and MR sever-








B-type natriuretic peptide (BNP) correlates with symptoms,
exercise capacity, and prognosis in congestive heart failure
(HF).1 In patients with chronic HF, the BNP level increases
in proportion to the degree of left ventricular (LV) dysfunc-
tion and the severity of mitral regurgitation (MR).2–4 Several
studies have shown that circulating BNP levels may rise
acutely as an evolving response to clinical instability result-
ing from acute HF, acute pulmonary embolism, or acute cor-
onary syndromes.5–7 More recently, short-term changes in
BNP levels have also been reported in patients with
exercise-induced myocardial ischaemia. In this setting, the
rise in BNP, although brief, could be reliably detected and
the magnitude of increase correlated with the extent of
inducible ischaemia.8 Although symptoms mainly occur
during exercise, there is little information on the potential
usefulness of measuring the exercise-induced changes in
BNP levels in chronic stable HF patients. Dynamic LV dyssyn-
chrony—changes in the sequence of electromechanical coup-
ling during exercise—has been shown to be associated with
dynamic MR, exertional symptoms, and reduced exercise
capacity and is correlated with the extent of MR improve-
ment in resynchronized patients.9–11 Whether
exercise-induced changes in the sequence of activation of
LV might be a trigger of BNP release has never been investi-
gated. We tested the hypothesis that an acute increase in
the extent of LV dyssynchrony during exercise may lead to
transient elevation in plasma levels of BNP, which could
serve as a biochemical marker of dynamic LV dyssynchrony.
Methods
Population
The present study concerned 57 consecutive patients (mean age,
66+10 years; range 45–80 years) in sinus rhythm with chronic
ischaemic LV dysfunction [mean ejection fraction (EF) 31+6%;
range 18–44%] and at least mild functional MR who underwent quan-
titative exercise Doppler echocardiography. All of them were stable
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since at least 1 month and none had the following exclusion criteria:
technically inadequate echocardiogram, more than trivial aortic
regurgitation, history of myocardial infarction ,6 months, atrial
ﬁbrillation or ﬂutter, and evidence of inducible ischaemia. All
patients were in New York Heart Association functional class II or
III. All patients gave their informed consent and the protocol was
approved by the Local Ethics Committee.
Exercise echocardiography
Beta-blockers were stopped 24 h before the test. A symptom-
limited graded bicycle exercise test was performed in the semi-
supine position on a tilting exercise table. After an initial workload
of 25 W maintained for 3 min, the workload was increased every
2 min by 25 W. Blood pressure and a 12-lead electrocardiogram
were recorded every 2 min. Two-dimensional and Doppler echocar-
diographic recordings were available throughout the test. The pre-
sence of inducible myocardial ischaemia was excluded by the use of
technetium-99m sestamibi single photon emission computed tom-
ography as previously described.12
Echocardiographic measurements
All echocardiographic parameters were obtained at rest and at peak
exercise in the same cycling semi-supine position (Vivid 7 imaging
device, GE Healthcare, UK). Quantitation of MR was performed by
averaging both the quantitative Doppler method using mitral and
aortic stroke volumes and the proximal isovelocity surface area
method as previously described.13 From the mitral inﬂow, the E-
and A-wave velocities, E-deceleration time, and E/A velocity ratio
were measured. LV end-diastolic and end-systolic volumes and left
atrial maximal volume were measured by the biapical Simpson
disk method. Colour-tissue Doppler imaging was performed in the
apical views (two, three, and four-chamber). Intra-LV dyssynchrony
was referred to as LV dispersion and systolic dyssynchrony index. LV
diastolic dispersion was determined as the difference between the
longest and the shortest times to early diastolic velocities. The sys-
tolic dyssynchrony index was deﬁned as the standard deviation of
the time-to-peak systolic velocities of the 12 LV segments (six
walls).9,10 Interventricular dyssynchrony was determined as the
difference between the time interval in the basal lateral segment
of the right ventricle and of the LV. Peak velocities during early
(Ea) and late (Aa) diastole obtained at the level of septal, lateral,
inferior, and anterior mitral annulus were measured separately
and averaged. The E/Ea ratio was then calculated.
Measurement of B-type natriuretic peptide levels
Two millilitres of venous blood were drawn at rest and at peak exer-
cise and placed in a vacutainer tube containing potassium ethylene-
diaminotetraacetic acid. The samples were placed within 30 min on
a Triage BNP test slide (Biosite Diagnostic, San Diego, CA, USA) and
analysed in the Biosite MeterPlus machine, a point-of-care test
based on ﬂuorescence immunoassay.
Statistical analyses
Data are expressed as mean+ SD. Student’s paired two-tailed t-test
was used to compare measurements obtained at rest and during
exercise. Categorical variables were compared with Fisher’s exact
test. A value of P, 0.05 was considered signiﬁcant. Linear
regression analysis was applied to study the correlation between
BNP at rest and at exercise and different parameters. To determine
independent predictors of BNP at rest and of exercise-induced
changes in BNP during exercise, a stepwise multiple linear
regression was performed (STATISTICA version 6). All variables
with a P, 0.10 were included in the multivariate model. To deter-
mine independent determinants of a decrease in BNP during exer-
cise, a logistic regression analysis was performed.
Results
Baseline and exercise characteristics
The QRS duration was 122+ 30 ms (QRS  120 ms in 33). Of
the 57 patients, 29 stopped exercise because of dyspnoea.
The test duration was 9+ 3.2 min for a maximum workload
of 84+ 22 W. During test, LV end-diastolic volume
remained unchanged, whereas end-systolic volume
decreased and EF increased (Table I). During test, BNP
increased from 375+ 356 pg/mL (34–1480, median
217 pg/mL) to 435+ 367 pg/mL (41–1622, median
292 pg/mL) (P , 0.0001). The median of BNP increment
during exercise was 26 pg/mL (250 to 613 pg/mL)
(Figure 1A). At peak exercise, MR severity as quantitated
by effective regurgitant oriﬁce (ERO) increased from
13+ 7 mm2 to 22+ 12 mm2. Inter- and intra-ventricular
dyssynchrony did not change signiﬁcantly during test.
However, LV synchronicity during exercise varied substan-
tially from one patient to another; most patients
experienced an increase in LV asynchrony, whereas others
(50%) experienced no change or a decrease in LV dyssyn-
chrony (Figure 1B). Left atrial volume, mitral
E-wave, mean peak Ea, and Aa velocities rose during
exercise, whereas mitral E-wave deceleration time
decreased. Contrary to E/A ratio, E/Ea ratio increased
signiﬁcantly.
Table 1 Patients characteristics at rest and at exercise
Rest Exercise P
BNP (pg/mL) 375+356 435+367 ,0.0001



























Left atrial volume (mL) 67+24 74+23 0.0002
Mitral E-wave (cm/s) 70+26 107+32 ,0.0001
Mitral A-wave (cm/s) 61+26 67+27 0.03




Peak Ea velocity (cm/s) 3.9+1.7 5.3+2.9 ,0.0001
Peak Aa velocity (cm/s) 4.2+1.9 5.1+2.2 0.0003
E/Ea (average annuli) 19+8 23+12 0.011
BNP, B-type natriuretic peptide; LV, left ventricular; A, late diastolic
transmitral ﬂow velocity; Aa, late diastolic mitral annular velocity; E,
early diastolic transmitral ﬂow velocity; Ea, early diastolic mitral
annular velocity.
BNP release in patients with systolic HF 497
Determinants of B-type natriuretic peptide at rest
Under resting conditions, BNP levels were not affected by
age, sex, QRS width, NYHA class, medical history, and treat-
ment. Correlation coefﬁcients between BNP levels and echo-
cardiographic parameters are presented in Table 2.
Conversely to LVEF (r ¼ 20.41), higher LV volumes were
associated with higher BNP. The strongest correlation was
observed with LV end-systolic volume. Greater left atrial
volume, larger ERO of MR, higher E/A and E/Ea ratios
were also associated with higher BNP (Figure 2). The corre-
lations with transtricuspid pressure gradient and the systolic
dyssynchrony index were signiﬁcant but weak. By stepwise
multiple regression analysis, the LV end-systolic volume
index (P , 0.0001), the severity of MR as quantitated
by ERO (P , 0.001), and the E/Ea ratio (P ¼ 0.002)
emerged as independent determinants of BNP levels at
rest (R2 ¼ 0.67).
Determinants of exercise-induced changes
in B-type natriuretic peptide levels
Determinants of exercise-induced changes in BNP levels
during exercise are depicted in Table 3. The wide range of
exercise-induced changes in BNP neither correlate with
levels at rest nor with clinical parameters and treatment.
At peak exercise, transtricuspid pressure gradient, LV systo-
lic dispersion, systolic dyssynchrony index, and E/Ea ratio
correlated with changes in BNP. The strongest correlations
with BNP changes were observed with the differences in sys-
tolic dyssynchrony index and in ERO. Examples of dynamic
changes in LV dyssynchrony are provided in Figure 3. In
multivariate analysis, a smaller change in systolic blood
pressure (P ¼ 0.04), a larger increase in ERO (P ¼ 0.017),
and in systolic dyssynchrony index (P ¼ 0.006) during exer-
cise emerged as independent determinants of exercise-
induced increases in BNP (R2 ¼ 0.45) (Figure 4).
Discussion
Cardiac BNP has emerged as a powerful diagnostic and prog-
nostic biomarker in HF patients.1–3 Under resting conditions,
the BNP level represents an indirect marker of the severity
of MR, LV remodelling, and the presence of increased LV
ﬁlling pressure. In the absence of inducible myocardial
ischaemia, exercise testing is accompanied by substantial
changes in BNP levels in patients with chronic systolic LV dys-
function. To the best of our knowledge, this study is the ﬁrst
to show that the extent of dynamic LV dyssynchrony results
in detectable increases in BNP levels during exercise.
Besides, the magnitude of changes in BNP also reﬂects the
dynamic behaviour of MR during test.
Plasma B-type natriuretic peptide levels at rest
BNP is mainly produced in response to myocardial stretch-
ing.14 In the normal state, plasma concentration of BNP—
resulting from both atrial and ventricular release—is very
low and largely inﬂuenced by patient age, gender, and
renal function.15–17 In the failing heart, the ventricle
becomes the dominant chamber for BNP production and
BNP levels rise proportionally to the extent of LV dysfunc-
tion.2 In severely depressed LV, BNP is notably increased in
patients with a Doppler echocardiographic restrictive
ﬁlling pattern, an enlarged LV, or a severe MR.3,4,18 The
present study conﬁrms and extends these previous obser-
vations. Indeed, BNP exhibited direct relations with LV end-
systolic volume—a witness of LV remodelling, E/Ea ratio—a
non-invasive estimate of mean pulmonary wedge pressure,
Figure 1 (A) Correlations between exercise-induced changes in B-type natriuretic peptide (BNP) and BNP at rest. (B) Correlations between
exercise-induced changes in systolic dyssynchrony index and the degree of dyssynchrony at rest. Diff, difference.
Table 2 Determinants of B-type natriuretic peptide levels at
rest
BNP at rest r P
LV end-diastolic volume index 0.68 ,0.0001
LV end-systolic volume index 0.71 ,0.0001
LV ejection fraction 20.4 0.0018
Transtricuspid pressure gradient 0.31 0.017
Systolic dyssynchrony index 0.36 0.006
Effective regurgitant oriﬁce 0.58 0.0002
Left atrial volume 0.56 ,0.0001
Mitral A wave 0.38 0.004
Mitral E/A wave 0.29 0.033
E/Ea 0.61 ,0.0001
LV, left ventricular; A, late diastolic transmitral ﬂow velocity; E, early
diastolic transmitral ﬂow velocity; Ea, early diastolic mitral annular
velocity.
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and the quantiﬁed degree of MR—a parameter associated
with LV volume overload. Furthermore, all these factors
inﬂuence symptoms and are predictive of an adverse
outcome.19
Dynamic changes in B-type natriuretic peptide
levels during exercise
Although modest, the dynamic nature of BNP release in
response to exercise has beenpreviously reported.20–22 In cor-
onary artery disease, the magnitude of rise in BNP is pro-
portional to the degree of inducible ischaemia.8 In patients
with HF, plasma BNP levels at exercise are related to LV end-
diastolic pressure and inversely correlated to cardiac index
at peak test.23,24 In the present study, exercise-induced
changes in BNP were moderately related to the level of BNP
in basal conditions. Most patients exhibited an increase in
BNP at peak exercise. The rise in BNP was greater in patients
with larger exercise-induced increases inMR severity and in LV
dyssynchrony and blunted changes in systolic blood pressure.
These dynamic changes are known to contribute to exertional
symptoms through pulmonary congestion and a limitation of
forward stroke volume adaptation during exercise.9,25 Thus,
the acute exacerbation in volume overload and in LV end-
diastolic wall tension during exercise might acutely trigger
BNP degranulation from cardiac myocytes.26 Inadequate
adaptation of peripheral circulation in these HF patients
might also contribute to LV dyssynchrony by progressivemodi-
ﬁcations in ventricular shape, which becomesmore spherical.
Transient increases in BNP levels in relation to the asynchro-
nous activation sequence of the LV have also been reported
in patients submitted to different cardiac pacing modes.27
The exercise-induced decrease in BNP was, in contrast,
observed in patients with a larger increase in LV dP/dt—a
marker of LV systolic performance—and smaller changes in
LV systolic dyssynchrony during exercise. Reduction in BNP
might be related to exhausted BNP production, higher BNP
clearance, or diminished BNP release secondary to improved
haemodynamic condition.28 Animal studies have indeed
suggested that production and/or release of BNP might be
independently regulated.29
Limitations
N-terminal pro-BNP has not been evaluated. However,
because N-terminal pro-BNP has a longer half-life than
BNP, its plasma concentrations may be less responsive to
exercise.20 Serial measurements of BNP were not performed
after the recovery period. Renal function that could affect
BNP levels at rest but not during exercise was not available.
Withdrawing of beta-blockers, although of short duration,
might affect the level of BNP at rest. Patients in NYHA
class IV were excluded. In these patients, both dynamic
MR and LV dyssynchrony could be more severe. The analysis
of tissue Doppler imaging parameters was performed
off-line. As a result, E/Ea ratio appears to be higher than
previously reported.30 No evaluation of strain and strain
rate parameters was performed to differentiate passive
from active motion.
Conclusion
Dynamic increases in MR severity and in LV dyssynchrony
during exercise are new ﬁndings contributing to exercise
intolerance in patients with chronic systolic LV dysfunction.
Both are associated with larger exercise-induced increases
in BNP levels. Further studies are however required to
determine the clinical utility of exercise BNP and its prog-
nostic impact in patients with systolic HF.
Figure 2 Correlations between B-type natriuretic peptide at rest and effective regurgitant oriﬁce (A) and E/Ea ratio (B).
Table 3 Determinants of exercise-induced changes in B-type
natriuretic peptide levels
BNP difference (exercise2rest) r P
Systolic blood pressure diff. 20.35 0.008
LV end-diastolic volume index diff. 0.37 0.005
Effective regurgitant oriﬁce at exercise 0.43 0.0007
Effective regurgitant oriﬁce diff. 0.58 ,0.0001
Transtricuspid pressure gradient at exercise 0.54 0.0001
Transtricuspid pressure gradient diff. 0.47 0.0003
Systolic dyssynchrony index at exercise 0.54 0.0001
Systolic dyssynchrony index diff. 0.56 ,0.0001
E/Ea at exercise 0.45 0.0005
LV, left ventricular; E, early diastolic transmitral ﬂow velocity; Ea, early
diastolic mitral annular velocity; diff., difference from rest to exercise.
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